Virus Inactivation by Formaldehyde and Common Lysis Buffers.
biosafety
inactivation
virus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
04 08 2023
04 08 2023
Historique:
received:
12
07
2023
revised:
26
07
2023
accepted:
01
08
2023
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Numerous mammalian viruses are routinely analyzed in clinical diagnostic laboratories around the globe or serve as indispensable model systems in viral research. Potentially infectious viral entities are handled as blood, biopsies, or cell and tissue culture samples. Countless protocols describe methods for virus fixation and inactivation, yet for many, a formal proof of safety and completeness of inactivation remains to be shown. While modern nucleic acid extraction methods work quite effectively, data are largely lacking on possible residual viral infectivity, e.g., when assessed after extended culture times, which maximizes the sensitivity for low levels of residual infectiousness. Therefore, we examined the potency and completeness of inactivation procedures on virus-containing specimens when applying commonly used fixatives like formaldehyde or nucleic acid extraction/lysis buffers. Typical representatives of different virus classes, including RNA and DNA viruses, enveloped and non-enveloped, such as adenovirus, enterovirus, lentivirus, and coronavirus, were used, and the reduction in the in vitro infectiousness was assessed for standard protocols. Overall, a 30-minute incubation with formaldehyde at room temperature effectively inactivated all tested enveloped and non-enveloped viruses. Full inactivation of HIV-1 and ECHO-11 was also achieved with all buffers in the test, whereas for SARS-CoV-2 and AdV-5, only five of the seven lysis buffers were fully effective under the tested conditions.
Identifiants
pubmed: 37632035
pii: v15081693
doi: 10.3390/v15081693
pmc: PMC10458352
pii:
doi:
Substances chimiques
Formaldehyde
1HG84L3525
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Med Microbiol Immunol. 2021 Aug;210(4):235-244
pubmed: 34196781
Cytotechnology. 1999 May;29(3):221-7
pubmed: 19003345
Proteins. 2005 Nov 15;61(3):492-9
pubmed: 16152629
Arch Virol. 1998;143(11):2109-31
pubmed: 9856097
Med Microbiol Immunol. 2005 Jan;194(1-2):1-6
pubmed: 15118911
Cell Rep Methods. 2023 May 23;3(6):100485
pubmed: 37426753
Virol Sin. 2021 Feb;36(1):141-144
pubmed: 32458296
Pathogens. 2022 Feb 19;11(2):
pubmed: 35215213
View (Beijing). 2020 Jun;1(2):e16
pubmed: 34766164